Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 34 Squamous Cell Carcinoma of Head and Neck 22 Uterine Cervical Neoplasms 19 Lung Neoplasms 19 Small Cell Lung Carcinoma 16 Oropharyngeal Neoplasms 14 Ovarian Neoplasms 12 Carcinoma 10 Urinary Bladder Neoplasms 9 Stomach Neoplasms 9 Mouth Neoplasms 9 Laryngeal Neoplasms 9 Fallopian Tube Neoplasms 9 Hypopharyngeal Neoplasms 8 Cholangiocarcinoma 8 Pancreatic Neoplasms 7 Mesothelioma, Malignant 7 Medulloblastoma 7 Breast Neoplasms 7 Adenocarcinoma of Lung 7 Neuroblastoma 6 Nasopharyngeal Carcinoma 6 Gallbladder Neoplasms 6 Ganglioneuroblastoma 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Lymphoid Interstitial Pneumonia 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4

Interventions

Fluorouracil 9 Radiotherapy 7 Cisplatin 7 Radiotherapy, Intensity-Modulated 4 Mitomycin 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiation 3 Nivolumab 3 Capecitabine 3 dehydroftorafur 2 Taxes 2 Paclitaxel 2 Cetuximab 2 Carboplatin 2 Biopsy 2 toripalimab 1 rocakinogene sifuplasmid 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 VGX-3100 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Platinum × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡